Indian Regulators Propose Longer Postmarket Surveillance of Drugs

Drug Industry Daily
A A
India plans to extend its postmarket surveillance requirements for drugs from four years to six under a Ministry of Health proposal.

To View This Article:

Login

Subscribe To Drug Industry Daily